ACM
NVO

Absolute Capital Management’s Novo Nordisk NVO Stock Holding History

Absolute Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-48
Closed -$2.41K – 372
2022
Q3 		$2.41K Buy
+48
New +$2.57K ﹤0.01% 289
2022
Q1 		– Sell
-48
Closed -$2.69K – 358
2021
Q4 		$2.69K Buy
+48
New +$2.6K ﹤0.01% 307

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Absolute Capital Management's NVO Position: Q4 2022 in Review

Absolute Capital Management sold out of Novo Nordisk (NVO) in Q4 2022, closing a stake of 48 shares — an estimated $2.41K sold.

Absolute Capital Management first reported a position in NVO in Q4 2021 and held it in 2 quarters. The position peaked at $2.69K in Q4 2021. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Absolute Capital Management reported no remaining Novo Nordisk position as of Q4 2022 after selling out during the quarter.
  • Absolute Capital Management sold 48 Novo Nordisk shares in Q4 2022, an estimated $2.41K.
  • Absolute Capital Management first reported a position in Novo Nordisk in Q4 2021 and held it in 2 quarters.
  • Absolute Capital Management's Novo Nordisk position peaked at $2.69K in Q4 2021.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Absolute Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.